LeConte Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
LeConte Wealth Management's IDXX Position: Q3 2026 in Review
LeConte Wealth Management increased its Idexx Laboratories (IDXX) stake by 3.4% in Q3 2026, buying an estimated $8.77K and bringing the position to 482 shares worth $252K. The position accounts for 0.13% of the portfolio, ranked #145.
LeConte Wealth Management first reported a position in IDXX in Q3 2025 and has held it in 5 quarters since. The position peaked at $304K in Q4 2025. 1,273 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- LeConte Wealth Management held 482 shares of Idexx Laboratories worth $252K as of Q3 2026.
- LeConte Wealth Management bought 16 Idexx Laboratories shares in Q3 2026, an estimated $8.77K.
- Idexx Laboratories made up 0.13% of LeConte Wealth Management's portfolio in Q3 2026, its #145 holding.
- LeConte Wealth Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 5 quarters since.
- LeConte Wealth Management's Idexx Laboratories position peaked at $304K in Q4 2025.
- 1,273 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.